165 related articles for article (PubMed ID: 21807464)
1. Cyto-reductive Surgery combined with Hyperthermic Intra-peritoneal Chemotherapy for Peritoneal Surface Malignancies: current treatment and results.
Sommariva A; Pilati P; Rossi CR
Cancer Treat Rev; 2012 Jun; 38(4):258-68. PubMed ID: 21807464
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Br J Surg; 2010 Dec; 97(12):1874-80. PubMed ID: 20806291
[TBL] [Abstract][Full Text] [Related]
5. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
6. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
7. [Updated treatment of peritoneal carcinomas: a review].
Deraco M; Laterza B; Kusamura S; Baratti D
Minerva Chir; 2007 Dec; 62(6):459-76. PubMed ID: 18091656
[TBL] [Abstract][Full Text] [Related]
8. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
9. Anesthetic management in patients undergoing hyperthermic chemotherapy.
Raspe C; Piso P; Wiesenack C; Bucher M
Curr Opin Anaesthesiol; 2012 Jun; 25(3):348-55. PubMed ID: 22517311
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy.
Verwaal VJ
Cancer J; 2009; 15(3):212-5. PubMed ID: 19556907
[TBL] [Abstract][Full Text] [Related]
11. The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC).
Sommariva A; Zagonel V; Rossi CR
Ann Surg Oncol; 2012 Nov; 19(12):3737-44. PubMed ID: 22805859
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of delayed hyperthermic intraperitoneal chemotherapy in case of unforeseen complications.
Mohr Z; Hirche C; Liebeskind U; Rau B; Hünerbein M
Eur Surg Res; 2011; 47(1):19-25. PubMed ID: 21540615
[TBL] [Abstract][Full Text] [Related]
13. Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis.
De Simone M; Barone R; Vaira M; Aghemo B; Mioli P; Franco C; Scuderi S; Costamagna D; Dei Poli M
J Surg Oncol; 2003 Feb; 82(2):138-40. PubMed ID: 12561072
[No Abstract] [Full Text] [Related]
14. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
Di Giorgio A; Cardi M; Sammartino P
Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
[No Abstract] [Full Text] [Related]
15. [Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].
Kavanagh M; Ouellet JF;
Bull Cancer; 2006 Sep; 93(9):867-74. PubMed ID: 16980229
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
G Chir; 2011 Apr; 32(4):211-33. PubMed ID: 21554854
[TBL] [Abstract][Full Text] [Related]
17. [Cancers of the stomach and peritoneal carcinoses: will hyperthermia be a new therapeutic approach?].
Gilly FN; Carry PY; Sayag AC; Panteix GG; Bienvenu J; Brachet A; Salle B; Braillon G
Ann Chir; 1993; 47(5):414-8. PubMed ID: 8215164
[TBL] [Abstract][Full Text] [Related]
18. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
[TBL] [Abstract][Full Text] [Related]
19. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea.
Esquivel J
Cancer J; 2009; 15(3):249-54. PubMed ID: 19556912
[TBL] [Abstract][Full Text] [Related]
20. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Piso P; Glockzin G; von Breitenbuch P; Popp FC; Dahlke MH; Schlitt HJ; Nissan A
J Surg Oncol; 2009 Sep; 100(4):317-20. PubMed ID: 19697438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]